Newsroom
August 20, 2024
Study will evaluate biomarkers and novel treatments for alcohol use disorder Brett Ginsburg, PhD, director of the Biochemical Pharmacology Analytical Laboratory at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), was selected as a performer with the Wellcome Leap Untangling Addiction program. Wellcome Leap is a U.S.-based nonprofit organization […]
August 9, 2024
This news segment mentions that scientists from The University of Texas Health Science Center at San Antonio led a pilot study showing that the antiretroviral drug lamivudine shows potential for Alzheimer’s disease treatment. Watch Now
August 9, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
August 9, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
August 9, 2024
Monica Verduzco-Gutierrez, MD, professor and chair of the Department of Physical Medicine and Rehabilitation, and director of its long COVID clinics, was featured in this story. Read More
August 9, 2024
Andrew Brenner, MD, PhD, professor and chair of neuro-oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More